NCT04360850 is a clinical trial of online survey in Online Therapy, sponsored by University of Washington.

Who is sponsoring NCT04360850?

NCT04360850 is sponsored by University of Washington.

What drugs are being tested in NCT04360850?

Interventions in NCT04360850: online survey.

What condition does NCT04360850 study?

NCT04360850 studies Online Therapy.

Is NCT04360850 still recruiting?

NCT04360850 is currently completed. Last updated 29 October 2021.

Last reviewed 2021-10-29 · How we verify

NCT04360850

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic

Completed Last updated 29 October 2021

What this trial tests

trial testing online survey in Online Therapy in 818 participants. Completed in 3 June 2020.

Timeline

24 April 2020

Primary endpoint
3 June 2020

3 June 2020

Quick facts

Lead sponsor	University of Washington
Status	Completed
Study type	OBSERVATIONAL
Enrollment	818
Start date	24 April 2020
Primary completion	3 June 2020
Estimated completion	3 June 2020
Sites	1 location across United States

Drugs / interventions tested

online survey

Conditions studied

Online Therapy — all drugs for Online Therapy →

Sponsor

University of Washington

Who can join

18 and older, any sex, with Online Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A brief online survey to be completed by clinical therapists.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Therapists Make the Switch to Telepsychology to Safely Continue Treating Their Patients During the COVID-19 Pandemic. Virtual Reality Telepsychology May Be Next.
Sampaio M, Haro MVN, De Sousa B, Melo WV, et al · · 2021 · cited 35× · PMID 33585834 · DOI 10.3389/frvir.2020.576421
Spanish-Speaking Therapists Increasingly Switch to Telepsychology During COVID-19: Networked Virtual Reality May Be Next.
Sampaio M, Navarro Haro MV, Wilks C, De Sousa B, et al · · 2021 · cited 6× · PMID 34182825 · DOI 10.1089/tmj.2021.0124
The COVID-19 Trial Finder.
Sun Y, Butler A, Lin F, Liu H, et al · · 2021 · cited 4× · PMID 33216120 · DOI 10.1093/jamia/ocaa304

Verify or expand the search:

Other trials of online survey

Trials testing the same drug.

NCT07483905 — Interest in Nighttime Day Hospital Chemotherapy Infusions Among Gynecologic Cancer Patients · not yet recruiting
NCT05843994 — Artificial Intelligence Patient App for RDEB SCCs · active not recruiting
NCT05234034 — Intensity of Physical Activity Level During Daily Living: Unravelling Its Relationship With Chronic Musculoskeletal Diso · unknown
NCT04921826 — Potential Causes of Retained Items During Surgery · unknown
NCT04661462 — Health After Covid-19 in Tyrol · unknown

Other University of Washington trials

Trials by the same sponsor.

NCT07430852 — Inherited and Environmental Risks Acting on Body Weight · NA · not yet recruiting
NCT07466498 — Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Canc · Phase 2 · not yet recruiting
NCT06422299 — Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Youn · NA · not yet recruiting
NCT07322341 — SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer · Phase 2 · not yet recruiting
NCT07332351 — Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04360850 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Washington
Last refreshed: 29 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04360850.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing